These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2528436)

  • 1. N-acetylator variability in Down's syndrome: characterization with caffeine.
    Morris ME; Griener JC; Msall ME
    Clin Pharmacol Ther; 1989 Sep; 46(3):359-66. PubMed ID: 2528436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.
    Tang BK; Kadar D; Qian L; Iriah J; Yip J; Kalow W
    Clin Pharmacol Ther; 1991 Jun; 49(6):648-57. PubMed ID: 2060254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation polymorphism of caffeine in a Japanese population.
    Hashiguchi M; Ebihara A
    Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.
    el-Yazigi A; Chaleby K; Martin CR
    J Clin Pharmacol; 1989 Mar; 29(3):246-50. PubMed ID: 2723111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.
    el-Yazigi A; Chaleby K; Martin CR
    Clin Chem; 1989 May; 35(5):848-51. PubMed ID: 2566399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human N-acetylation genotype determination with urinary caffeine metabolites.
    Kilbane AJ; Silbart LK; Manis M; Beitins IZ; Weber WW
    Clin Pharmacol Ther; 1990 Apr; 47(4):470-7. PubMed ID: 2328555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylator phenotyping via analysis of four caffeine metabolites in human urine by micellar electrokinetic capillary chromatography with multiwavelength detection.
    Guo R; Thormann W
    Electrophoresis; 1993; 14(5-6):547-53. PubMed ID: 8354241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative test for acetylator phenotyping with caffeine.
    Tang BK; Kadar D; Kalow W
    Clin Pharmacol Ther; 1987 Nov; 42(5):509-13. PubMed ID: 3677540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population and family study of N-acetyltransferase using caffeine urinary metabolites.
    Bechtel YC; Bonaiti-Pellie C; Poisson N; Magnette J; Bechtel PR
    Clin Pharmacol Ther; 1993 Aug; 54(2):134-41. PubMed ID: 8354022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual and intraindividual variability in acetylation: characterization with caffeine.
    Hardy BG; Lemieux C; Walker SE; Bartle WR
    Clin Pharmacol Ther; 1988 Aug; 44(2):152-7. PubMed ID: 3396262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of acetylator phenotype in Caucasians with caffeine.
    Hildebrand M; Seifert W
    Eur J Clin Pharmacol; 1989; 37(5):525-6. PubMed ID: 2598993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
    Asprodini EK; Zifa E; Papageorgiou I; Benakis A
    Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple test for acetylator phenotype using caffeine.
    Grant DM; Tang BK; Kalow W
    Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
    Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
    Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
    Jetter A; Kinzig M; Rodamer M; Tomalik-Scharte D; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2009 Apr; 65(4):411-7. PubMed ID: 19082994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test.
    Klebovich I; Rautio A; Salonpää P; Arvela P; Pelkonen O; Sotaniemi EA
    Biomed Pharmacother; 1995; 49(5):225-7. PubMed ID: 7579000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.